CoChat

ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan

Open access
Olin-Lewis, Katherine, Krauss, Ronald M., La Belle, Michael, Blanche, Patricia J., Barrett, P.Hugh R., Wight, Thomas N., Chait, Alan · 2002 · Journal of Lipid Research

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

Abstract

Retention of apolipoprotein (apo)B and apoE-containing lipoproteins by extracellular vascular proteoglycans is critical in atherogenesis. Moreover, high circulating apoC-III levels are associated with increased atherosclerosis risk. To test whether apoC-III content of apoB-containing lipoproteins affects their ability to bind to the vascular proteoglycan biglycan, we evaluated the impact of apoC-III on the interaction of [(35)S]SO(4)-biglycan derived from cultured arterial smooth muscle cells with lipoproteins obtained from individuals across a spectrum of lipid concentrations. The extent of biglycan binding correlated positively with apoC-III levels within VLDL (r = 0.78, P < 0.01), IDL (r = 0.67, P < 0.01), and LDL (r = 0.52, P < 0.05). Moreover, the biglycan binding of VLDL, IDL, and LDL was reduced after depletion of apoC-III-containing lipoprotein particles in plasma by anti-apoC-III immunoaffinity chromatography. Since apoC-III does not bind biglycan directly, enhanced biglycan binding may result from a conformational change associated with increased apo C-III content by which apoB and/or apoE become more accessible to proteoglycans. This may be an intrinsic property of lipoproteins, since exogenous apoC-III enrichment of LDL and VLDL did not increase binding. ApoC-III content may thus be a marker for lipoproteins characterized as having an increased ability to bind proteoglycans.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1194/jlr.m200322-jlr200

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 LDL binds to biglycan with high affinity. A: Autoradiograph of a gel from the electrophoretic gel mobility shift assay is shown. Increasing concentrations of VLDL, IDL, and LDL from a subject were incubated with a fixed amount (0.19 𝛍 M) of [ 35 S]SO4-labeled biglycan for 1 h at 37 ° C prior to electrophoresis in agarose, as described in Materials and Methods. Biglycan that binds lipoproteins remains at the origin, or migrates a short distance into the gel. Free, unbound [ 35 S]SO4-biglycan migrates to the front of the gel. B: The binding curves for the interaction of VLDL (circle), IDL (square), and LDL (triangle) and [ 35 S]SO4-labeled biglycan that were shown in A. The amount of bound versus free [ 35 S]SO4-biglycan for each lane was calculated, and plotted against the concentration of total protein for that lipoprotein sample. The inset shows the same data as a Scatchard plot. Data are from a single experiment that is representative of lipoprotein samples from 24 subjects.
Fig. 1 LDL binds to biglycan with high affinity. A: Autoradiograph of a gel from the electrophoretic gel mobility shift assay is shown. Increasing concentrations of VLDL, IDL, and LDL from a subject were incubated with a fixed amount (0.19 𝛍 M) of [ 35 S]SO4-labeled biglycan for 1 h at 37 ° C prior to electrophoresis in agarose, as described in Materials and Methods. Biglycan that binds lipoproteins remains at the origin, or migrates a short distance into the gel. Free, unbound [ 35 S]SO4-biglycan migrates to the front of the gel. B: The binding curves for the interaction of VLDL (circle), IDL (square), and LDL (triangle) and [ 35 S]SO4-labeled biglycan that were shown in A. The amount of bound versus free [ 35 S]SO4-biglycan for each lane was calculated, and plotted against the concentration of total protein for that lipoprotein sample. The inset shows the same data as a Scatchard plot. Data are from a single experiment that is representative of lipoprotein samples from 24 subjects.CC-BY · From the PDF
Fig. 2 Within each lipoprotein class, the amount of apoC-III correlates positively with the ability of the lipoprotein to bind biglycan. Hyperbolic regression curves are shown to demonstrate the correlation of a lipoprotein's apoC-III content with the amount of biglycan bound to samples of lipoprotein (VLDL, circle; IDL, square; LDL, triangle) that contained 0.05 mg/ml total protein. For the interaction, samples were incubated with a fixed amount (0.19 𝛍 M) of [ 35 S]SO4-labeled biglycan for 1 h at 37 ° C prior to electrophoresis in agarose, as described in Materials and Methods.
Fig. 2 Within each lipoprotein class, the amount of apoC-III correlates positively with the ability of the lipoprotein to bind biglycan. Hyperbolic regression curves are shown to demonstrate the correlation of a lipoprotein's apoC-III content with the amount of biglycan bound to samples of lipoprotein (VLDL, circle; IDL, square; LDL, triangle) that contained 0.05 mg/ml total protein. For the interaction, samples were incubated with a fixed amount (0.19 𝛍 M) of [ 35 S]SO4-labeled biglycan for 1 h at 37 ° C prior to electrophoresis in agarose, as described in Materials and Methods.CC-BY · From the PDF
Fig. 3 Within each lipoprotein class, the amount of apoC-III correlates with the affinity constant ( Ka ) for the interaction of the lipoprotein with biglycan. Hyperbolic regression curves are shown to demonstrate the correlation of a lipoprotein's apoC-III content with the affinity constant ( Ka ) calculated from the interaction with biglycan (VLDL, circle; IDL, square; LDL, triangle). For the interaction, samples were incubated with a fixed amount (0.19 𝛍 M) of [ 35 S]SO4-labeled biglycan for 1 h at 37 ° C prior to electrophoresis in agarose, as described in Materials and Methods.
Fig. 3 Within each lipoprotein class, the amount of apoC-III correlates with the affinity constant ( Ka ) for the interaction of the lipoprotein with biglycan. Hyperbolic regression curves are shown to demonstrate the correlation of a lipoprotein's apoC-III content with the affinity constant ( Ka ) calculated from the interaction with biglycan (VLDL, circle; IDL, square; LDL, triangle). For the interaction, samples were incubated with a fixed amount (0.19 𝛍 M) of [ 35 S]SO4-labeled biglycan for 1 h at 37 ° C prior to electrophoresis in agarose, as described in Materials and Methods.CC-BY · From the PDF
Fig. 4 Increased binding of biglycan to lipoproteins that contain apoC-III compared to apoC-III-depleted lipoproteins. Binding curves are shown for the interaction of biglycan and apoC-III-containing (A) VLDL, (B) IDL, and (C) LDL (open circle), or VLDL, IDL, and LDL isolated from the same plasma sample that had been passed over an anti-human apoC-III column (closed circle). Equal numbers of lipoprotein particles were incubated with a fixed amount (0.19 𝛍 M) of [ 35 S]SO4-labeled biglycan for 1 h at 37 ° C prior to electrophoresis in agarose, as described in Materials and Methods. The insets show the same data as Scatchard plots. The data are from a single experiment that is representative of two independent experiments.
Fig. 4 Increased binding of biglycan to lipoproteins that contain apoC-III compared to apoC-III-depleted lipoproteins. Binding curves are shown for the interaction of biglycan and apoC-III-containing (A) VLDL, (B) IDL, and (C) LDL (open circle), or VLDL, IDL, and LDL isolated from the same plasma sample that had been passed over an anti-human apoC-III column (closed circle). Equal numbers of lipoprotein particles were incubated with a fixed amount (0.19 𝛍 M) of [ 35 S]SO4-labeled biglycan for 1 h at 37 ° C prior to electrophoresis in agarose, as described in Materials and Methods. The insets show the same data as Scatchard plots. The data are from a single experiment that is representative of two independent experiments.CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 54 references

Cited by

See all 114

Metadata

Authors
Olin-Lewis, K., Krauss, R. M., La Belle, M., Blanche, P. J., Barrett, P. H. R., Wight, T. N., & Chait, A.
Affiliations
  • Lawrence Berkeley National Laboratory (US)
  • The University of Western Australia (AU)
  • University of Washington (US)
Corresponding author
Chait, Alan
Venue
Journal of Lipid Research
Publisher
Elsevier BV
Published
2002-11
Volume
43
Issue
11
Pages
1969-1977
ISSN
0022-2275 (ISSN-L)
OpenAlex
W2015816213
Cited by
114
References
54
Citations by year
2026: 5 · 2025: 6 · 2024: 10 · 2023: 6 · 2022: 4 · 2021: 7 · 2020: 10 · 2019: 2 · 2018: 5 · 2017: 1 · 2016: 7 · 2015: 3 · 2014: 3 · 2013: 2 · 2012: 6
FWCI
4.14
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Lipid Research (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institutes of Health (HL30086)
  • U.S. Public Health Service (12609)
  • National Heart, Lung, and Blood Institute (P01HL030086, HL3-0086, HL 18754)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK 02456, DK35816-16, P30DK035816)
  • National Center for Research Resources
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
Keywords
apolipoprotein C-III, biglycan, apolipoprotein B, apolipoprotein E, VLDL, IDL, low-density lipoprotein, atherosclerosis, atherogenesis, arterial smooth muscle cells, immunoaffinity chromatography
MeSH terms
Apolipoproteins B, Apolipoproteins C, Chromatography, Affinity, Humans, Lipoproteins, Lipoproteins, LDL, Lipoproteins, VLDL, Particle Size, Proteoglycans, Extracellular Matrix Proteins, Apolipoprotein C-III, Biglycan

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan. https://app.cochat.ai/papers/10.1194/jlr.m200322-jlr200
The paper
Olin-Lewis, K., Krauss, R. M., La Belle, M., Blanche, P. J., Barrett, P. H. R., Wight, T. N., & Chait, A. (2002). ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan. Journal of Lipid Research. https://doi.org/10.1194/jlr.m200322-jlr200

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.